143 related articles for article (PubMed ID: 19912521)
1. Whole blood manganese concentrations in dogs with congenital portosystemic shunts.
Gow AG; Marques AI; Yool DA; Duncan A; Mellanby RJ
J Vet Intern Med; 2010; 24(1):90-6. PubMed ID: 19912521
[TBL] [Abstract][Full Text] [Related]
2. Whole blood manganese concentrations in dogs with primary hepatitis.
Kilpatrick S; Jacinto A; Foale RD; Tappin SW; Burton C; Frowde PE; Elwood CM; Powell R; Duncan A; Mellanby RJ; Gow AG
J Small Anim Pract; 2014 May; 55(5):241-6. PubMed ID: 24593275
[TBL] [Abstract][Full Text] [Related]
3. Plasma cytokine concentrations in dogs with a congenital portosystemic shunt.
Kilpatrick S; Gow AG; Foale RD; Tappin SW; Carruthers H; Reed N; Yool DA; Woods S; Marques AI; Jalan R; Mellanby RJ
Vet J; 2014 Apr; 200(1):197-9. PubMed ID: 24518641
[TBL] [Abstract][Full Text] [Related]
4. "Hepatic volume measurements in dogs with extrahepatic congenital portosystemic shunts (CPSS) before and after surgical attenuation" by Kummeling et al (2010;24:114-119).
Impellizeri JA
J Vet Intern Med; 2010; 24(3):453; author reply 454. PubMed ID: 20565565
[No Abstract] [Full Text] [Related]
5. Thromboelastographic evaluation of dogs with congenital portosystemic shunts.
Kelley D; Lester C; DeLaforcade A; Webster CR
J Vet Intern Med; 2013; 27(5):1262-7. PubMed ID: 23815243
[TBL] [Abstract][Full Text] [Related]
6. Endogenous benzodiazepine activity in the peripheral and portal blood of dogs with congenital portosystemic shunts.
Aronson LR; Gacad RC; Kaminsky-Russ K; Gregory CR; Mullen KD
Vet Surg; 1997; 26(3):189-94. PubMed ID: 9150556
[TBL] [Abstract][Full Text] [Related]
7. Serum melatonin in dogs with congenital portosystemic shunting, with and without hepatic encephalopathy.
Ferreira MDF; Mellanby RJ; Gow AG
Vet Rec; 2020 Aug; 187(3):e23. PubMed ID: 31974269
[TBL] [Abstract][Full Text] [Related]
8. Serum haptoglobin concentrations in dogs with liver disease.
Crawford K; Warman SM; Marques AI; Yool DA; Eckersall PD; McCulloch E; Lynn K; Mellanby RJ; Gow AG
Vet Rec; 2013 Dec; 173(23):579. PubMed ID: 24158322
[TBL] [Abstract][Full Text] [Related]
9. Association between hepatic histopathologic lesions and clinical findings in dogs undergoing surgical attenuation of a congenital portosystemic shunt: 38 cases (2000-2004).
Lee KC; Winstanley A; House JV; Lipscomb V; Lamb C; Gregory S; Jalan R; Mookerjee RP; Brockman DJ
J Am Vet Med Assoc; 2011 Sep; 239(5):638-45. PubMed ID: 21879964
[TBL] [Abstract][Full Text] [Related]
10. Markers of hepatic regeneration associated with surgical attenuation of congenital portosystemic shunts in dogs.
Tivers MS; Lipscomb VJ; Smith KC; Wheeler-Jones CP; House AK
Vet J; 2014 May; 200(2):305-11. PubMed ID: 24662025
[TBL] [Abstract][Full Text] [Related]
11. Association of portovenographic findings with outcome in dogs receiving surgical treatment for single congenital portosystemic shunts: 45 cases (2000-2004).
Lee KC; Lipscomb VJ; Lamb CR; Gregory SP; Guitian J; Brockman DJ
J Am Vet Med Assoc; 2006 Oct; 229(7):1122-9. PubMed ID: 17014361
[TBL] [Abstract][Full Text] [Related]
12. Transvenous coil embolisation for the treatment of single congenital portosystemic shunts in six dogs.
Bussadori R; Bussadori C; Millán L; Costilla S; Rodríguez-Altónaga JA; Orden MA; Gonzalo-Orden JM
Vet J; 2008 May; 176(2):221-6. PubMed ID: 17466545
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor (VEGF) and VEGF receptor expression in biopsy samples of liver from dogs with congenital portosystemic shunts.
Tivers MS; Lipscomb VJ; Scase TJ; Priestnall SL; House AK; Gates H; Wheeler-Jones CP; Smith KC
J Comp Pathol; 2012 Jul; 147(1):55-61. PubMed ID: 21996035
[TBL] [Abstract][Full Text] [Related]
14. Comparison of survival after surgical or medical treatment in dogs with a congenital portosystemic shunt.
Greenhalgh SN; Dunning MD; McKinley TJ; Goodfellow MR; Kelman KR; Freitag T; O'Neill EJ; Hall EJ; Watson PJ; Jeffery ND
J Am Vet Med Assoc; 2010 Jun; 236(11):1215-20. PubMed ID: 20513200
[TBL] [Abstract][Full Text] [Related]
15. Hepatic volume measurements in dogs with extrahepatic congenital portosystemic shunts before and after surgical attenuation.
Kummeling A; Vrakking DJ; Rothuizen J; Gerritsen KM; van Sluijs FJ
J Vet Intern Med; 2010; 24(1):114-9. PubMed ID: 20391636
[TBL] [Abstract][Full Text] [Related]
16. A prospective study of basal insulin concentrations in dogs with congenital portosystemic shunts.
Collings AJ; Gow AG; Marques A; Yool D; Furneaux R; Mellanby R; Watson PJ
J Small Anim Pract; 2012 Apr; 53(4):228-33. PubMed ID: 22417097
[TBL] [Abstract][Full Text] [Related]
17. Liver size, bodyweight, and tolerance to acute complete occlusion of congenital extrahepatic portosystemic shunts in dogs.
Doran IP; Barr FJ; Hotston Moore A; Knowles TG; Holt PE
Vet Surg; 2008 Oct; 37(7):656-62. PubMed ID: 19134088
[TBL] [Abstract][Full Text] [Related]
18. Long-term survival and quality of life in dogs with clinical signs associated with a congenital portosystemic shunt after surgical or medical treatment.
Greenhalgh SN; Reeve JA; Johnstone T; Goodfellow MR; Dunning MD; O'Neill EJ; Hall EJ; Watson PJ; Jeffery ND
J Am Vet Med Assoc; 2014 Sep; 245(5):527-33. PubMed ID: 25148094
[TBL] [Abstract][Full Text] [Related]
19. Serum hyaluronic acid in dogs with congenital portosystemic shunts.
Seki M; Asano K; Sakai M; Kanno N; Teshima K; Edamura K; Tanaka S
J Small Anim Pract; 2010 May; 51(5):260-3. PubMed ID: 20402843
[TBL] [Abstract][Full Text] [Related]
20. Requests clarification on study of congenital portosystemic shunts.
Willard M
J Am Vet Med Assoc; 2010 Sep; 237(6):624; author reply 624. PubMed ID: 20839980
[No Abstract] [Full Text] [Related]
[Next] [New Search]